Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 3 Radiotherapy 2 Drug Therapy 2 pirarubicin 1 pazopanib 1 liposomal doxorubicin 1 capmatinib 1 anlotinib 1 Triptorelin Pamoate 1 Trabectedin 1 Radiation 1 Methotrexate 1 Ifosfamide 1 Fatty Acids, Omega-3 1 Cisplatin 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Sarcoma × pirarubicin × Clear all

NCT03342300 2020-05-19

PDVPSTS

Peking University People's Hospital

Phase 2/3 Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡